Why the study?
Experience with the transcatheter bicaval valve system for tricuspid regurgitation is still scarce.
This case report highlights a novel safety concern (thrombosis) associated with the emerging transcatheter bicaval valve system for tricuspid regurgitation.
Answers are grounded in this paper and cite their sources.
Thrombosis risk warrants vigilance with bicaval valves in tricuspid regurgitation; leaves open optimal antithrombotic strategies.
The transcatheter bicaval valve system is an emerging therapeutic option for tricuspid regurgitation, consisting of 2 biological valves to prevent caval reflux. The experience with this device is still scarce, and to the best of our knowledge, this is the first case of thrombosis ever reported. (Level of Difficulty: Advanced.)
No takes yet. Share an insight, caveat, or question.
Custódio et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: